Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion

Patrick Gérardin, Georges Barau, Alain Michault, Marc Bintner, Hanitra Randrianaivo, Ghassan Choker, Yann Lenglet, Yasmina Touret, Anne Bouveret, Philippe Grivard, Karin Le Roux, Séverine Blanc, Isabelle Schuffenecker, Thérèse Couderc, Fernando Arenzana-Seisdedos, Marc Lecuit, Pierre-Yves Robillard, Patrick Gérardin, Georges Barau, Alain Michault, Marc Bintner, Hanitra Randrianaivo, Ghassan Choker, Yann Lenglet, Yasmina Touret, Anne Bouveret, Philippe Grivard, Karin Le Roux, Séverine Blanc, Isabelle Schuffenecker, Thérèse Couderc, Fernando Arenzana-Seisdedos, Marc Lecuit, Pierre-Yves Robillard

Abstract

Background: An outbreak of chikungunya virus affected over one-third of the population of La Réunion Island between March 2005 and December 2006. In June 2005, we identified the first case of mother-to-child chikungunya virus transmission at the Groupe Hospitalier Sud-Réunion level-3 maternity department. The goal of this prospective study was to characterize the epidemiological, clinical, biological, and radiological features and outcomes of all the cases of vertically transmitted chikungunya infections recorded at our institution during this outbreak.

Methods and findings: Over 22 mo, 7,504 women delivered 7,629 viable neonates; 678 (9.0%) of these parturient women were infected (positive RT-PCR or IgM serology) during antepartum, and 61 (0.8%) in pre- or intrapartum. With the exception of three early fetal deaths, vertical transmission was exclusively observed in near-term deliveries (median duration of gestation: 38 wk, range 35-40 wk) in the context of intrapartum viremia (19 cases of vertical transmission out of 39 women with intrapartum viremia, prevalence rate 0.25%, vertical transmission rate 48.7%). Cesarean section had no protective effect on transmission. All infected neonates were asymptomatic at birth, and median onset of neonatal disease was 4 d (range 3-7 d). Pain, prostration, and fever were present in 100% of cases and thrombocytopenia in 89%. Severe illness was observed in ten cases (52.6%) and mainly consisted of encephalopathy (n = 9; 90%). These nine children had pathologic MRI findings (brain swelling, n = 9; cerebral hemorrhages, n = 2), and four evolved towards persistent disabilities.

Conclusions: Mother-to-child chikungunya virus transmission is frequent in the context of intrapartum maternal viremia, and often leads to severe neonatal infection. Chikungunya represents a substantial risk for neonates born to viremic parturients that should be taken into account by clinicians and public health authorities in the event of a chikungunya outbreak.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Monthly Evolution of Neonatal, Maternal…
Figure 1. Monthly Evolution of Neonatal, Maternal Pre- and Intrapartum, and Antepartum Chikungunya Cases between March 2005 (m1) and June 2006 (m16), First Sud-Réunion Outbreak, in Saint-Pierre
Figure 2. Representative MRI Findings in Neonatal…
Figure 2. Representative MRI Findings in Neonatal Chikungunya Encephalopathy Cases Observed during the First Chikungunya Outbreak in Saint-Pierre, La Réunion, June 2005 to December 2006
(A) Day 6 (child A), scattered hyperintensity signals of the white matter involving the corpus callosum, the frontal and parietal lobes on diffusion-weighted imaging (DWI). (B) Day 6 (child A), scattered reduction of the Apparent Diffusion Coefficient (ADC) of the white matter involving the corpus callosum, the frontal and parietal lobes on ADC mapping (in blue). (C) Day 21 (child B), scattered and characteristic hypo-intensity signals of the white matter involving frontal and parietal lobes on DWI (Note that the corpus callosum remains in hyper-signal). (D) Day 21 (child B), scattered increase of the ADC of the white matter involving the corpus callosum, the frontal and parietal lobes on ADC mapping (in red).

References

    1. Porterfield JH. Antigenic characteristics and classification of the Togaviridae. In: Schlesinger R, editor. The Togaviruses. New York: Academic Press; 1980. pp. 13–46.
    1. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory in 1952–53. 1. Clinical features. Trans R Soc Trop Med Hyg. 1955;49:28–32.
    1. Ross RW. The Newala epidemic. III. The virus: Isolation, pathogenic properties and relationship to the epidemic. J Hyg (London) 1956;54:177–191.
    1. Lumsden WHR. An epidemic of virus disease in Southern Province, Tanganyika Territory in 1952–53. 11. General description and epidemiology. Trans R Soc Trop Med Hyg. 1955;49:33–57.
    1. Hammon W, Rudnick A, Sather GE. Virus associated with hemorrhagic fevers of the Philippines and Thaïland. Science. 1960;131:1102–1103.
    1. Shah KV, Gibbs CJ, Jr., Banergee G. Virological investigation of the epidemic of hemorrhagic fever in Calcutta: isolation of three strains of Chikungunya virus. Indian J Med Res. 1964;52:676–683.
    1. Mac Intosh BM, Jupp PG, Dos-Santos I. Rural epidemic of chikungunya in South Africa with involvement of Aedes furcifer and baboons. S Afr J Sci. 1977;73:267–269.
    1. Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg. 1999;60:281–286.
    1. Schuffenecker I, Iteman I, Michault A, Murri S, Franqeul L, et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e263. doi: .
    1. Paganin F, Borgherini G, Staikowsky F, Arvin-Berod C, Poubeau P. Chikungunya à l'île de la Réunion: chronique d'une épidémie annoncée. Presse Med. 2006;35:641–646.
    1. Reiter P, Fontenille D, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem. Lancet Infect Dis. 2006;6:463–464.
    1. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, et al. Outbreak of chikungunya on reunion island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44:1401–1407.
    1. Robillard PY, Boumahni B, Gérardin P, Michault A, Fourmaintraux A, et al. Transmission verticale materno-fœtale du virus chikungunya. Presse Med. 2006;35:785–788.
    1. Barau G, Robillard PY, Hulsey TC, Dedecker F, Laffite A, et al. Linear association between maternal pre-pregnancy body mass index and risk of caesarean section in term deliveries. BJOG. 2006;113:1173–1177.
    1. Staikowsky F, Le Roux K, Schuffenecker I, Laurent P, Grivard P, et al. Retrospective survey of Chikungunya disease in Reunion Island hospital staff. Epidemiol Infect. 2007;136:196–206.
    1. Pialoux G, Gaüzere BA, Jaureguiberry S, Strobel S. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:319–327.
    1. Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Biol. 2000;38:1823–1826.
    1. Grivard P, Le Roux K, Laurent P, Fianu A, Perrau J, et al. Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris) 2007;55:490–494.
    1. Pastorino B, Bessaud M, Grandadam S, Murri H, Tolou JH, et al. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. J Virol Methods. 2005;124:65–71.
    1. Laurent P, Le Roux K, Grivard P, Bertil G, Naze F, et al. Development of a sensitive real time reverse transcriptase PCR assay with an internal control to detect and quantify Chikungunya virus. Clin Chem. 2007;53:1408–1414.
    1. Amiel-Tison C. A method for neurologic evaluation within the first year of life. Curr Probl Pediatr. 1976;7:1–50.
    1. Touret Y, Randrianaivo H, Michault A, Schuffenecker I, Kauffmann E, et al. Transmission materno-foetale précoce du virus Chikungunya. Presse Med. 2006;35:1656–1658.
    1. Jadhav M, Namboodripad M, Carman RH, Carey DE, Myers RM. Chikungunya disease in infants and children in Vellore: a report of clinical and haematological features of virologically proved cases. Indian J Med Res. 1965;53:764–776.
    1. Lenglet Y, Barau G, Robillard PY, Randrainaivo H, Michault A, et al. Infection à Chikungunya chez la femme enceinte et transmission materno-fœtale. J Gynecol Obstet BiolReprod (Paris) 2006;35:578–583.
    1. Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, et al. A mouse model for chikungunya: Young age and inefficient type-i interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4(2):e29. doi: .
    1. Kennedy AC, Fleming J, Solomon L. Chikungunya viral arthropathy: a clinical description. J Rheumatol. 1980;7:231–236.
    1. Rehle TM. Classification, distribution and importance of arboviruses. Trop Med Parasitol. 1989;40:391–395.
    1. Ramful D, Carbonnier M, Pasquet M, Bouhmani B, Ghazouani J, et al. Mother-to-child transmission of Chikungunya virus infection. Pediatr Infect Dis J. 2007;26:811–815.
    1. Fraser JR. Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis. 1986;12:369–388.
    1. Del Giudice P, Schuffenecker I, Zeller H, Grelier M, Vandenbos F, et al. Skin manifestations of West Nile virus infection. Dermatology. 2005;211:348–350.
    1. Fadilah SA, Sahrir S, Raymond AA, Cheong SK, Aziz JA, et al. Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage. Southeast Asian J Trop Med Public Health. 1999;30:710–717.
    1. Sumarmo Talago W, Asrin A, Isnuhandojo B, Sahudi A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics. 1992;69:45–49.
    1. Asher DP, Laws HF, Hayes CG. The use of intravenous gammaglobulin in dengue fever, a case report. Southeast Asian J Trop Med Public Health. 1989;20:549–554.
    1. Nimmannitiya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962–1964. Am J Trop Med Hyg. 1969;18:954–971.
    1. O'Leary DR, Kuhn S, Kniss KL, Hinckey AF, Rasmussen AS, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003–2004. Pediatrics. 2006;117:537–545.
    1. Ali M, Safriel Y, Sohi J, Llave A, Weathers S. West Nile virus infection: MR imaging findings in the nervous system. Am J Neuroradiol. 2005;26:289–297.
    1. Carles G, Pfeiffer G, Talarmin A. Effects of dengue fever during pregnancy in French Guiana. Clin Infect Dis. 1999;28:637–640.
    1. Siranavin S, Nuntnarumit P, Supapannachart S, Boonkasidecha S, Techasaensiri C, et al. Vertical dengue infection: case reports and review. Pediatr Infect Dis J. 2004;23:1042–1047.
    1. Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans. 2006;34:22–29.
    1. Watanaveeradej V, Endy TP, Simasathien S, Kerdpanich A, Polpprasert N, et al. Transplacental Chikungunya virus antibody kinetics, Thailand. Emerg Infect Dis. 2006;12:1770–1772.
    1. Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks—the globalization of vectorborne diseases. N Engl J Med. 2007;356:769–771.
    1. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370:1840–1846.

Source: PubMed

3
S'abonner